Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1996 | 09-1996 | 06-1996 | 03-1996 | 12-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,955 | 0 | 0 | 0 | -17,292 |
| Depreciation Amortization | 3,895 | 0 | 0 | 0 | 3,081 |
| Other Working Capital | -3,368 | 0 | 0 | 0 | -637 |
| Other Operating Activity | 645 | -5,926 | -320 | -3,394 | 12,259 |
| Operating Cash Flow | $-3,783 | $-5,926 | $-320 | $-3,394 | $-2,589 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,301 | -1,993 | -779 | -258 | -1,315 |
| Other Investing Activity | -47,506 | -17,050 | -8,931 | -2,147 | 2,497 |
| Investing Cash Flow | $-53,807 | $-19,043 | $-9,710 | $-2,405 | $1,182 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 64,099 | 59,246 | 59,206 | 5,495 | 6,544 |
| Financing Cash Flow | $64,099 | $59,246 | $59,206 | $5,495 | $6,544 |
| Beginning Cash Position | 18,828 | 18,828 | 18,828 | 18,828 | 13,691 |
| End Cash Position | 25,337 | 53,105 | 68,004 | 18,524 | 18,828 |
| Net Cash Flow | $6,509 | $34,277 | $49,176 | $-304 | $5,137 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,783 | -5,926 | -320 | -3,394 | -2,589 |
| Free Cash Flow | -3,783 | -5,926 | -320 | -3,394 | -2,589 |